discogenic low back pain, transforaminal surgery
Conditions
Interventions
therapy group:Bushen Huoxue Prescription (1) Composition: Eucommia 15g, Psoralen 10g, Achyranthes bidentata 10g, Salvia miltiorrhiza 12g, Clematis 10g, papaya 9g
(2) Usage: 1 dose per day, divided into morning and evening
(3) Course of treatment: 2 weeks.
control group:ibuprofen sustained release capsules (1) Specification: 0.3g, 24 capsules per box
(2) Usage: Take orally, 1 capsule at a time, 2 times a day
Sponsors
China Academy of Chinese Medical Sciences Wangjing Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients with MRI diagnosis of intervertebral disc injury (discogenic low back pain, transforaminal surgery); (2) VAS=3 and VAS=7; (3) The TCM syndrome is Kidney Deficiency and Blood Stasis Syndrome; (4) Age 20-60 years old; (5) Sign the informed consent and become a subject voluntarily.
Exclusion criteria
Exclusion criteria: (1) patients with lumbar tuberculosis, lumbar tumor, lumbar compression fracture or severe osteoporosis. (2) complicated infection, organ failure, etc. (3) patients with cauda equina syndrome. (4) patients with adverse reactions to traditional Chinese medicine or ibuprofen sustained-release capsules. (5) patients with coagulation mechanism or platelet dysfunction. (6) pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical efficiency;Lumbar mobility;Oswestry disability index,ODI;VAS score; | — |
Countries
china
Contacts
Public ContactFeng Minshan
China Academy of Chinese Medical Sciences Wangjing Hospital
Outcome results
None listed